Follow
Rare Cancer
Rare cancers are characterized by the National Institute of Health as those malignancies which inflect less than 40,000 people annually in the United States. Combined, all rare cancers account for about 25% of all cancer diagnoses. Unfortunately, research and development of new therapies for rare cancers is challenging, resulting in slow progress for new therapeutic approaches. While rare cancers exist in many organs throughout the body, all childhood cancers are considered rare.
MAR 01, 2023 | 8:00 AM
Date: March 01, 2023 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CET) Characterizing metastasis remains key for understanding and eradicating cancer. The study of circulating tumor cells (CTC...
DEC 08, 2022 | 9:00 AM
Date: December 8, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Liquid biopsy enables non-invasive testing and monitoring in oncology, but also comes with unique challenges. In this...
NOV 02, 2022 | 6:00 AM
The CRISPR revolution has begun and shows no signs of slowing down. CRISPR-Cas nuclease-based genome editing strategies hold great promise for the treatment of genetic disorders. However, a...
OCT 05, 2022 | 3:00 PM
Uterine leiomyosarcoma (uLMS) is a rare aggressive sarcoma of the smooth muscle layer of the uterus manifested in high local recurrence and metastatic rate. Currently, effective treatment of...
OCT 05, 2022 | 7:30 AM
Key to precision oncology is the development of expert databases that organize and standardize information on cancer-related genetic variants, as well as their associated diagnostic, prognos...
OCT 04, 2022 | 6:00 AM
Targeted sequencing has many applications in cancer biomarker research, carrier screening and inherited disorders, drug development, mitochondrial DNA variant detection, human ID and paterni...
SEP 22, 2022 | 10:00 AM
Date: September 22, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Digital PCR (dPCR) is a specialized approach to nucleic acid detection ......
JUN 28, 2022 | 9:00 PM
Date: June 29, 2022 Time: 12:00pm (PST), 2:00pm (EST), 8:00pm (CEST) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the ne...
MAY 25, 2022 | 10:00 AM
Date: May 25, 2022 Time: 10:00am (PDT), 1:00pm (EDT), 7:00pm (CEST) Programmable RNA base editors are excellent tools to modify RNA transcripts at precise locations or designated hotspots. P...
MAY 03, 2022 | 8:00 AM
Cancer is a disease of the genome, and as such, tools that can analyze the genome are instrumental in understanding the mechanisms that lead to cancer, detecting cancerous cells, and providi...
APR 20, 2022 | 1:30 PM
The speakers will discuss how to surmount obstacles related to translating sequencing data into actionable results, and propose curated variant content shared with the clinical community as...
APR 19, 2022 | 12:00 PM
Targeted sequencing has many applications in cancer biomarker research, carrier screening and inherited disorders, drug development, mitochondrial DNA variant detection, human ID and paterni...
MAR 24, 2022 | 8:00 AM
Date: March 24, 2022 Time: 8:00am (PST), 11:00am (EST), 4:00pm (GMT) Key to precision oncology is the development of expert databases that organize and standardize information on cancer-rel...
NOV 02, 2021 | 9:00 AM
Date: November 2, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Flow cytometry is a powerful technique for the analysis of multiple parameters of individual cells within heterogeneous populations....
OCT 27, 2021 | 8:00 AM
Date: October 27, 2021 Time: 8:00am (PDT), 11:00am (EDT) Learn about how brightfield images can take your flow cytometry data to the next level. Join Dr. Cora Chadick, Technical Director, as...